The global juvenile idiopathic arthritis diagnostic market is projected to reach USD 9,302.8 million by 2034, up from an estimated USD 6,284.6 million in 2024. This steady growth, with a CAGR of 4.0% during the forecast period (2024-2034), underscores the increasing need for early diagnosis and improved treatment options in managing juvenile arthritis. In 2023, …